MedTrace Logo

Lactate Values During Labour and Their Correlation With Maternal and Foetal Outcome

NCT06807255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 303

Last updated 2025-02-07

No results posted yet for this study

Summary

Postpartum haemorrhage (PPH) represents a significant cause of morbidity in the obstetric population, with a mortality rate of 140,000 women per year, and the predominant cause of PPH (70%) is uterine atony.

Consequently, elevated lactate levels during labour could influence maternal and foetal well-being. We decided to assess lactate concentrations during labour in women receiving neuraxial anaesthesia and evaluate the association between high lactate levels and adverse maternal and foetal outcomes.

The secondary aims of the study were to assess lactate levels at different stages of labour and investigate whether increased lactate concentrations could influence neonatal cord pH upon delivery.

Conditions

  • Lactate Values During Labour in Women Receiving Neuraxial Anaesthesia

Interventions

DIAGNOSTIC_TEST

Lactate levels were assessed via a venous blood gas test utilising an IV cannula already placed in the woman's limb upon admission

Lactate levels were assessed via a venous blood gas test utilising an IV cannula already placed in the woman's limb upon admission; subsequent analysis was conducted using rapid processing (under 5 minutes from the pre-test) with the Rapidpoint 500 Systems-Siemens (Siemens, Milano) emogasanalyzer

Sponsors & Collaborators

  • Papa Giovanni XXIII Hospital

    lead OTHER

Principal Investigators

  • Giulia Fierro, MD · ASST Papa Giovanni XXIII

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-09-30
Completion
2023-10-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06807255 on ClinicalTrials.gov